[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-360655-105":59,"doc-detail-360655-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","potential-activity-of-non-platinum-metal-based-organic-complexes-against-different-cancer-cell-types","Potential Activity of Non-Platinum Metal-Based Organic Complexes Against Different Cancer Cell Types","","The disadvantages of Cisplatin in anticancer treatment stem from limited selectivity, emerging cancer resistance, and toxicity to normal organs. The review highlights synthesis and clinical investigation of non-platinum metal complexes designed for stronger anticancer effects and better selectivity with reduced toxicity, side effects, and resistance. It summarizes potential non-platinum metal-based organic therapeutic agents across diverse cancer cell types, drawing from literature on arsenic, boron, antimony, selenium, and multiple metals.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/potential-activity-of-non-platinum-metal-based-organic-complexes-against-different-cancer-cell-types/360655/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/potential-activity-of-non-platinum-metal-based-organic-complexes-against-different-cancer-cell-types/360655.png","ImageObject",300,407,{"name":92,"@type":93},"4398046744996","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-07","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is Cisplatin limited in anticancer therapy?","Question",{"text":112,"@type":113},"Cisplatin has poor selectivity, cancers develop resistance to the drug, and it shows toxicity against normal organs.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What is the main goal of the review?",{"text":117,"@type":113},"To summarize the potential of important non-platinum metal-based organic compounds as therapeutic agents against different cancer cell types.",{"name":119,"@type":110,"acceptedAnswer":120},"Which non-platinum metal complexes are described as having stronger activity than Cisplatin?",{"text":121,"@type":113},"Organocomplexes of copper, ferrocene, and ruthenium are reported to be more active, with copper and ruthenium complexes particularly more selective.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},360655,1790291773,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":66,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":133,"file_id":134,"file_url":135,"file_type":136,"file_size":137,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":138,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},4398046744996,"Review  \nPotential Activity of Non-Platinum Metal-Based Organic Complexes Against Different Cancer Cell Types  \nDobrina Tsvetkova 1,*, Stefka Ivanova 2 and Danka Obreshkova 3  \nAcademic Editor: Andrew Knight  \nReceived: 1 June 2025  \nRevised: 25 May 2026  \nAccepted: 28 May 2026  \nPublished: 12 June 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Medical University-Sofia, Dunavstr. 2, 1000 Sofia, Bulgaria  \n2 Bulgarian Pharmaceutical Society, 1000 Sofia, Bulgaria; ivanovastefka_pharm@yahoo.com  \n3 Multi-Profile Emergency Department, UMHATEM “N.I. Pirogov”, 1606 Sofia, Bulgaria; [phddanka@yahoo.com](phddanka@yahoo.com)  \n* [Correspondence: dtsvetkova@pharmfac.mu-sofia.bg](Correspondence: dtsvetkova@pharmfac.mu-sofia.bg); Tel.: +359-878895009  \nAbstract  \nThe disadvantages of Cisplatin in anticancer treatment are connected to its poor selectivity, resistance developed of cancers to the drug, and its toxicity against normal organs. An important strategy in anticancer treatment is the synthesis and clinical investigation of non-platinum metal complexes with superior anticancer activity and improved selectivity compared to Cisplatin, combined with lower toxicity, fewer side effects and decreased resistance of cancer to the drug. In the current study, we aim to summarize the potential of important non-platinum metal-based organic compounds as therapeutic agents against different cancer cell types. The review covers the general principles of chemotherapy. A literature analysis shows that organic complexes of the metalloids arsenic (As), boron (B), antimony (Sb), and selenium (Se), and of metals, such as Ag, Au, Co, Cu, Fe, Mn, Mo, Ni, Zn, Ce, Ga, Gd, Ir, Os, Pd, Re, Rh, Ru, Ti, and V, have been investigated for potential applications in cancer therapy. This is due to their antiproliferative effects against different cancer types: lung [Cd(II), Co(II), Cu(II), Ni(II), Mn(II), Ru(II), Zn(II)]; breast [Ag(I), Cu(I), Cu(II), Ir(III), Ni(II), Mn(II),. Rh(III), Ru(II)]; gastric [Cu(II), Cu(II)-La(III)]; colon [Ag(I), Cu(II), Ir(III), Pd(II), Rh(III), Ru(II), vanadium(V)]; colorectal [Ag(I), Co(II), Cu(II), Zn(II)]; liver [Ag(I), Co(II), Cu(II), Gd(III), vanadium(V)]; pancreatic [vanadium(IV)]; bladder [Ag(I), Cu(II), Ru(II)]; cervical [Ag(I), Au(I), Cu(I), Cu(II), Fe(II), Ir(III), Rh(III), Ru(II)]; testicular [vanadium(IV)]; prostate [Cu(II), Pd(II), Zn(II)]; leukemia [Ag(I), Co(II), Cu(II), Pd(II), Zn(II)]; sarcoma [Co(II), Ni(II), Zn(II)]; mesothelioma [Cu(II)]; neuroblastoma [Cu(II)]; glioma [Cu(II)]; and melanoma [Au(I), Cu(II), Pd(II), Ru(II)] . The main goals for increasing anticancer metal-based complexes include increasing anticancer activity and selectivity, reducing toxicity, and avoiding cancer cell resistance. Compared to Cisplatin, organocomplexes of copper, ferrocene, and ruthenium are more active. Ruthenium and copper complexes, in particular, are also more selective. Notably, ruthenium and ferrocene derivatives are less toxic than Cisplatin. Lastly, cancers appear to exhibit less resistance against copper, gold, ruthenium, palladium, and ferrocene complexes.  \nKeywords: non-platinum metal–organic complexes; anticancer activity; selectivity; toxicity; resistance  \n1. Introduction  \nMalignant cancers, of which there are over 100 different types, are the leading cause of lethality worldwide [1] .  \nNon-platinum metal-based organic complexes have been found to exert a potential antiproliferative effect against different cancer cell types: lung, breast, gastric, colon, colorectal, liver, pancreatic, bladder, cervical, testicular, prostate, leukemia, sarcoma, mesothelioma, neuroblastoma, brain glioma, and melanoma [1] . Risk factors for cancer development are important to know, as this can contribute to mor","cbCaigHxNFEcxs9E","https://ap.wps.com/l/cbCaigHxNFEcxs9E","pdf",2279985,32,"English","# Abstract\n# Introduction\n# Risk Factors for Cancer Development","[{\"question\":\"Why is Cisplatin limited in anticancer therapy?\",\"answer\":\"Cisplatin has poor selectivity, cancers develop resistance to the drug, and it shows toxicity against normal organs.\"},{\"question\":\"What is the main goal of the review?\",\"answer\":\"To summarize the potential of important non-platinum metal-based organic compounds as therapeutic agents against different cancer cell types.\"},{\"question\":\"Which non-platinum metal complexes are described as having stronger activity than Cisplatin?\",\"answer\":\"Organocomplexes of copper, ferrocene, and ruthenium are reported to be more active, with copper and ruthenium complexes particularly more selective.\"}]","Potential Activity of Non-Platinum Metal-Based Organic Complexes Against Different Cancer Cell Types | PDF",1790140910,81,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bf8174bb0d5b548686c2df11456e900c.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/29e5ba6dcbb7044f90bdb21dfdb6385c.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ae6302ea8fa581b36ea3542a63d3af2e.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/14895eba861674fb8a62f05a67d39fd9.webp",980,1385]